Phase II randomized adjuvant trial of dose-dense docetaxel before or after doxorubicin/cyclophosphamide (AC) in axillary node-positive breast cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2015
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 16 Apr 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 27 Oct 2011 Planned End Date (1 Dec 2011) added as reported by ClinicalTrials.gov.